PA(18:3(9Z,12Z,15Z)/20:2(11Z,14Z)) (BioCAD00000109747)

{$topic}

Metabolite Card

Formula: C41H71O8P (722.4886)
SMILES: [H][C@@](COC(=O)CCCCCCC\C=C/C\C=C/C\C=C/CC)(COP(O)(O)=O)OC(=O)CCCCCCCCC\C=C/C\C=C/CCCCC

Synonyms [en]

PA(18:3(9Z,12Z,15Z)/20:2(11Z,14Z)); PA(38:5); 1-(9Z,12Z,15Z-octadecatrienoyl)-2-(11Z,14Z-eicosadienoyl)-glycero-3-phosphate; [(2R)-2-[(11Z,14Z)-icosa-11,14-dienoyloxy]-3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyloxy]propoxy]phosphonic acid; Phosphatidic acid(38:5); PA(18:3_20:2)

Reviewed

Last reviewed on 2024-06-28.

Cite this Page

PA(18:3(9Z,12Z,15Z)/20:2(11Z,14Z)). 数据之源，洞见之始. SMRUCC genomics institute, a synthetic life researcher from China. https://biocad_registry.innovation.ac.cn/s/(-)-arctiin (retrieved 2026-01-03) (CAD Registry RN: BioCAD00000109747). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).

Note

PA(18:3(9Z,12Z,15Z)/20:2(11Z,14Z)) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(18:3(9Z,12Z,15Z)/20:2(11Z,14Z)), in particular, consists of one chain of alpha-linolenic acid at the C-1 position and one chain of eicosadienoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

Entity Information

DBLinks

Other DBLinks
  • PubChem: 52929006
  • ChEBI: ChEBI:170269
  • HMDB: HMDB0115524
  • LipidMaps: LMGP10010413
  • Metlin: METLIN_81579

Class / Ontology

Metabolic Network
ID EC Number Name
View More
Organism Source

Taxonomy Source

Pathway Synthetic

pathway id name
PathBank:SMP0067144 De Novo Triacylglycerol Biosynthesis TG(18:3(9Z,12Z,15Z)/20:2(11Z,14Z)/20:3(5Z,8Z,11Z))
PathBank:SMP0067148 De Novo Triacylglycerol Biosynthesis TG(18:3(9Z,12Z,15Z)/20:2(11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PathBank:SMP0067152 De Novo Triacylglycerol Biosynthesis TG(18:3(9Z,12Z,15Z)/20:2(11Z,14Z)/22:4(7Z,10Z,13Z,16Z))
PathBank:SMP0067156 De Novo Triacylglycerol Biosynthesis TG(18:3(9Z,12Z,15Z)/20:2(11Z,14Z)/24:0)
PathBank:SMP0033382 De Novo Triacylglycerol Biosynthesis TG(18:3(9Z,12Z,15Z)/20:2(11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PathBank:SMP0075892 De Novo Triacylglycerol Biosynthesis TG(18:3(9Z,12Z,15Z)/20:2(11Z,14Z)/20:3(5Z,8Z,11Z))
PathBank:SMP0075896 De Novo Triacylglycerol Biosynthesis TG(18:3(9Z,12Z,15Z)/20:2(11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PathBank:SMP0075900 De Novo Triacylglycerol Biosynthesis TG(18:3(9Z,12Z,15Z)/20:2(11Z,14Z)/22:4(7Z,10Z,13Z,16Z))
PathBank:SMP0075904 De Novo Triacylglycerol Biosynthesis TG(18:3(9Z,12Z,15Z)/20:2(11Z,14Z)/24:0)
PathBank:SMP0091166 De Novo Triacylglycerol Biosynthesis TG(18:3(9Z,12Z,15Z)/20:2(11Z,14Z)/20:3(5Z,8Z,11Z))
PathBank:SMP0091170 De Novo Triacylglycerol Biosynthesis TG(18:3(9Z,12Z,15Z)/20:2(11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PathBank:SMP0091174 De Novo Triacylglycerol Biosynthesis TG(18:3(9Z,12Z,15Z)/20:2(11Z,14Z)/22:4(7Z,10Z,13Z,16Z))
PathBank:SMP0091178 De Novo Triacylglycerol Biosynthesis TG(18:3(9Z,12Z,15Z)/20:2(11Z,14Z)/24:0)
PathBank:SMP0067143 De Novo Triacylglycerol Biosynthesis TG(18:3(9Z,12Z,15Z)/20:2(11Z,14Z)/20:2(11Z,14Z))
PathBank:SMP0067147 De Novo Triacylglycerol Biosynthesis TG(18:3(9Z,12Z,15Z)/20:2(11Z,14Z)/20:4(8Z,11Z,14Z,17Z))
PathBank:SMP0067151 De Novo Triacylglycerol Biosynthesis TG(18:3(9Z,12Z,15Z)/20:2(11Z,14Z)/22:2(13Z,16Z))
PathBank:SMP0067155 De Novo Triacylglycerol Biosynthesis TG(18:3(9Z,12Z,15Z)/20:2(11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PathBank:SMP0033381 De Novo Triacylglycerol Biosynthesis TG(18:3(9Z,12Z,15Z)/20:2(11Z,14Z)/20:4(8Z,11Z,14Z,17Z))
PathBank:SMP0075891 De Novo Triacylglycerol Biosynthesis TG(18:3(9Z,12Z,15Z)/20:2(11Z,14Z)/20:2(11Z,14Z))
PathBank:SMP0075895 De Novo Triacylglycerol Biosynthesis TG(18:3(9Z,12Z,15Z)/20:2(11Z,14Z)/20:4(8Z,11Z,14Z,17Z))
View All Pathways